DIABETES mellitus (DM), long considered a disease of minor importance to global health, is now a major threat to human health 1 . DM is becoming the leading cause of death in developed countries, being the fourth or fifth most common non-communicable diseases worldwide 2 . It is estimated that by 2025, 300 million people will be diabetic or prediabetic 3 . Developing countries such as India have seen maximum increase in DM in the last few years. In general, people with diabetes either totally lack insulin (type-1 diabetes mellitus or T1DM) or have too little insulin or cannot use it efficiently (type-2 diabetes mellitus or T2DM); T2DM accounts for 90-95% of all diabetic patients. DM is marked by raised blood glucose levels and is a heterogeneous group of diseases 4 . The increasing incidences of T2DM and its consequences in terms of cardiovascular morbidity and mortality represent a considerable public health problem 5 . Thus, for developing new therapeutic agents for the treatment of T2DM and other metabolic syndromes, it is necessary to identify the molecular targets of the transducers critically involved in the control of glucose and lipid homeostasis. For cellular and whole-body glucose and lipid homeostasis maintenance, metabolic nuclear receptor (NR) molecules are found to be a particularly attractive target and play a key role in controlling glucose and lipid homeostasis. Among these receptors, special attention has been paid for more than a decade to the members of the peroxisome proliferator-activated receptor (PPAR) family 6 . PPARs belong to the nuclear hormone receptor family and are defined as transcriptional factors that are activated by the binding of ligands to their ligand-binding domains (LBDs) 7 . There are three subtypes of PPARs 8 , namely PPAR-, PPAR-, and PPAR-, which share similar three-dimensional structure within LBDs, but display distinct tissue distribution pattern and different pharmacological profiles 9 . Thus ligands simultaneously activating all the PPARs can be strong candidates in relation to drugs and can be used to treat abnormal metabolic homeostasis. Derivatives of 3-(4-alkoxyphenyl) propanoic acid are synthetic ligands which exhibit unique PPAR agonistic activities 7 . Saturated and unsaturated fatty acids, endogenous metabolites and synthetic ligands are known to activate PPARs 10 . PPAR- is mostly expressed in liver, kidney, skeletal, heart muscles and adrenal glands, as these tissues are involved in lipid oxidation 11 . PPAR- is expressed in macrophages, vascular smooth muscles and adipose tissue 12 . PPAR- was first determined as a key regulator for differentiation of an adipocyte, but recent molecular-biological studies have indicated that PPAR- activation is also linked to the expression of many important genes such as TNF-, leptin and adiponectin genes that affect energy metabolism 13 . Development of indigenously engineered remedies and costeffective treatment become important as costs of synthetic drugs have increased now. Chemometric modelling is part of the enormous field of cheminformatic technology that has become popular among the pharmaceutical industries and researchers to designate the drug targets by means of computational tools. Structure-activity relationship (SAR), which is a statistical technique capable of analysing screening datasets and deriving predictive models of biologically interested activity, pharmacophore mapping and molecular docking are already proved vital chemometric techniques to optimize the drug candidates 14 . In the present study, these chemometric techniques are used to identify important features necessary for a compound to behave as an activator of PPAR- and PPAR- receptors. PPAR-/ transactivation activity is not examined, since the lead compound shows very weak PPAR-/ transactivation activity.
Materials and methods
In the present work a set of 46 phenylpropanoic acid derivatives (Table 1) have been considered for quantitative structure activity relationship (QSAR) 15 study to design potential lead compounds for the treatment of non-insulin dependent diabetes mellitus (NIDDM) 6, [16] [17] [18] [19] . Figure 1 shows a common scaffold of phenylpropanoic acid derivatives. QSAR is the study of the quantitative relationship between experimental activity of a set of compounds and their physico-chemical properties using statistical methods. Structure generation and minimization (using Chem3D ultra) 19 , descriptor generation (using MOE) 20 , and QSAR studies by means of multiple linear regressions (MLR) 21 and partial least squares (PLS) 21 analysis using SPSS 22 have been performed on the dataset. The interaction of the targets (PDB ID: 1FM9 and 1K7L) 23 with the most active compounds of the dataset has been observed via docking studies. A number of models have been generated and the best one selected based on high R 2 (correlation coefficient) and Q 2 (crossvalidated correlation coefficient) along with low se (standard error of estimation) and sp (standard error of prediction), and good prediction of test set compound.
QSAR
This is a mathematical relationship between biological activity of a molecule and its chemical properties or chemical structure, and is a widespread approach for predicting biological activities in drug design. It is based on the assumption that the changes in molecular features of compounds can be correlated with variations in their physico-chemical/structural properties.
where y is the biological activity and x is the chemical property or structural property. The effective concentration data on phenylpropanoic acid derivatives (Table 1) are taken from the literature 6, [16] [17] [18] [19] . The dataset is divided into a training set for generating QSAR models and a test set for validating the quality of the models. The dataset is divided randomly keeping in mind that biological activity of all compounds in the test set lies within maximum and minimum value range of biological activity of the training set compounds. The training set is considered for statistical analysis using MLR and PLS for model building methods 21 . QSAR models have been generated using the negative logarithm of half maximal effective concentration (pEC 50 ) values as the dependent variable and values of descriptors as independent variables. The independent variables (descriptors) are calculated from MOE and care is taken that the descriptors used for model generation do not have intercorrelation.
Docking studies
In order to check the binding interaction of the compound with PPAR- and PPAR- receptors, docking is performed. The molecular docking tool, MOE 20 , is used to study binding modes of the most active compound to the receptor molecule. Fine 3D structure with a resolution of 2.65 Å of nuclear receptors is retrieved from the Protein Data Bank (PDB) 23 . Hydrogen bonding interactions are the basic properties required for interaction between PPARs and phenylpropanoic acid receptors 24 . Docking algorithm is able to generate a large number of possible structures. Using this computational method, the preferred orientation of one molecule to a second when bound to each other to form a stable complex can be predicted 26 .
Pharmacophore analysis
Pharmacophores are a group of features that are significant in a set of molecules. A pharmacophore indicates important groups necessary for the binding of ligands to the receptor binding pocket. The most common features are the presence of hydrophobic, aromatic ring, hydrogen bond acceptor and donor groups. The pharmacophore model can be used for virtual screening of ligands as well as for the de novo design of ligands to create completely novel candidate structures that conform to the requirements of a given pharmacophore. Pharmacophores are basically of three types, i.e. structure-based, ligand-based and both receptor-and ligand-based in which structure of the receptor, structure of the ligand and structure of both receptor and ligand is required respectively. For a pharmacophore model preparation, several molecules are aligned to find common features among a set of molecules which can be used for pharmacophore searching.
Validation
This is an important step of any SAR model to evaluate predictivity and robustness. In this study, QSAR models are validated both internally and externally. The best models are validated internally using leave-one out (LOO) cross-validation method 26 followed by modified R 2 (r 2 m) prediction 27 . During LOO cross-validation procedure, one compound is deleted randomly from the training set and the model is regenerated using the rest of the compound in each cycle; the new model generated is used to predict the activity of the deleted compound. Better predictive ability of the model is explained by high Q 2 (>0.5) and low se (<0.5) values. r 2 m can be defined as the measure of the degree of deviation of the predicted activity from the observed ones, and the model may be considered if r 2 m >0. 
Results and discussion

QSAR study
Phenylpropanoic acid derivatives, a potent PPAR- and PPAR- activator and active at micro-molar level (Table  1) , are considered in the present work for molecular modelling. The biological activity, expressed as pEC 50 , is used as the dependent variable for modelling. A number of models have been prepared and the correlation coefficient is predicted using the MLR and PLS analysis method. The values of independent variables used in Model 1 are not inter-correlated (R < 0.5; Table 2 ). The statistical The model obtained from the MLR studies reveals the importance of TPSA (polar surface area), rsynth (feasibility of the chemical structure), SMR_VSA3 and SMR_VSA4 (subdivided surface areas) and vsurf_Wp7 (polar volume) descriptors for the interaction of ligand and receptor. PLS studies (model 2) justify that the polar surface area, subdivided surface area, feasibility of chemical structure and polar volume are crucial for the binding interaction of ligand and receptor. In the model, the negative value of the coefficient for polar surface area suggests that increase in polar surface area is responsible for an increase in the activity of the molecule. The positive coefficient for the polar volume indicates that an increase in the polar volume positively affects the activity of the ligands. The coefficient for the van der Waals surface area is also negative, which implies that increase in the surface area of ligands enhances the activity, and hence the interaction between ligand and receptor also increases. Furthermore, the smaller van der Waals surface area (SMR_VSA3) and polar volume of ligand have a positive impact on the effective concentration, as suggested by the positive value of the coefficient. Table 3 shows the values of the descriptors. The values of independent variables used in model 3 are not intercorrelated (R < 0.5; Table 4 Table 5 provides the predicted activity for training and test set compounds obtained from the model.
PPAR-
PLS analysis:
The model reveals the importance of number of angle bend potential energy (E_ang), fractional positive van der Waals surface area (PEOE_VSA_FPOS), atomic contribution to molar refractivity (BCUT_SMR_1), atom count and bond count descriptor (opr_leadlike) and partial charge (GCUT_PEOE_2) descriptors, which are also crucial in the MLR analysis. 
Validation of QSAR models
Internal validation: The activity of the training compounds is predicted using LOO cross-validation method in QSAR studies of both -and -subtypes. Q 2 is found to be 0.649 and 0.774 for model 1 and model 3 respectively, whereas SE 0.251 and 0.426 respectively. The r 2 m value for the respective models is 0.638 and 0.782. The statistical results (Q 2 and r 2 m > 0.5) of the both studies show that the selected models are robust.
External/test set validation:
The activity of the test compounds is predicted in QSAR studies. Correlation (R) between observed and estimated activities of test compounds is 0.777 and 0.917 for model 1 and model 3 respectively. In QSAR study, R 
Docking studies PPAR- :
To further observe the interactions, docking study is performed and the most active compound is docked for its binding interactions with the active site of (PDB 1FM9) protein. Hydrogen bond (HB) is the most widely used parameter for evaluation of docking results, as it is an influential parameter in the activity of the drug compound. The number of HB interactions is observed via docking. The docked conformation of compounds reveals that the compound interacts with the binding pocket residues (GLN286, ASP243, LYS232, HIS449, LYS232, GLU295 etc.) of targeted proteins through several favourable interactions, including HB donor and acceptor with residue GLU295 and LYS232 respectively ( Figure  3 ). The N atom present in the ligand behaves as a HB donor and interacts with the GLU295 residue, while the LYS232 residue interacts with terminal hydroxyl group which behaves like a HB acceptor. The HB feature is also observed in the QSAR studies.
PPAR-:
To further support the QSAR results, the most active compound is docked for its binding interactions in the active site of (PDB 1K7L) protein. Group R is at the entrance of the pocket and is surrounded by THR279, SER280, LEU321, PHE273, LYS257, GLU282 residues of targeted proteins (Figure 4) . The presence of a hydrogen bonding feature is found crucial for the interaction, which is also observed in the QSAR studies. Residue LYS257 and GLU282 are found to show favourable interaction, including HB donor and HB acceptor with the most active conformer. The GLU282 residue in receptor binding pocket interacts with the terminal hydroxyl group of most active conformer while the LYS257 residue shows HB interactions with the oxygen atom of carboxylic group of conformer.
The docking study is performed on the receptor molecules with the most active compound for both PPAR- and PPAR- reveals the importance of HB donor and acceptor character which is also observed in the QSAR studies, and hence signifying the validity of the model.
Validation of docking studies
The docking analysis between the receptor molecules PPAR- and PPAR- and the most active compound gives binding energy of -9.36 and -9.66 kcal/mol respectively, for the best docking pose. This is further compared with the binding energy for the interaction of available phenylpropanoic acid-based drug, ragaglitazar (zinc ID: ZINC01481830) 30 with the  and  subtypes, which is found to be -9.48 and -9.76 kcal/mol respectively. The obtained binding energy for the interaction falls within the threshold range (between -5 and -15 kcal/mol), which implies that the binding models for both subtypes are acceptable. Also, the above comparative analysis implies that the binding energy of interaction for the most active ligand with the respective receptors is close to that of the available drug and hence verifies the validity of the binding model.
Pharmacophore development
Using the Pharmacophore Query Editor tool in MOE, the Pharmacophore model has been developed. This application generates a pharmacophore query by a computerized representation of the binding interactions with a particular active site using a hypothesized pharmacophore. A pharmacophore query in MOE is a set of features created typically from ligand annotation points. The pharmacophore model is developed by alligning the five most active agonists ( Figure 5 ). It outlines six important pharmacophore features that are observed in the most active agonists: four polar atoms and functional groups capable of performing HB (F1, F2, F3, F4 and F5) , and aromatic structural elements (F6). The hydrophobic/aromatic features stabilize the positions of the hydrophilic ones; the terminal F1 donor and acceptor feature can form HB with the oxygen atom, which is also confirmed by docking interactions, and F6 features are directed inside and contribute additionally to the stabilization of the ligand pose into the pocket. F2, F3 and F4 are the acceptor features contributing to the hydrogen bond interaction as evidenced by docking interactions of LYS257 residue with F2 feature. Similar functions can be assigned to the F5 feature being the donor group of interacting with the GLU295 residue, either directly or through water molecules. Thus the hydroxyl group is found to be crucial for the binding of ligand to the receptor, as evident from the pharmacophore and docking studies.
Conclusion
From the MLR and PLS analysis studies of the compounds, we have obtained descriptors which contribute significantly to both subtypes. Features like polar surface area, van der Waals surface area and polar volume are important for better prediction of activity and binding interaction of ligands with the PPAR- receptor. Furthermore, features like angle bend potential energy, refractivity of ligands, partial charge and fractional positive van der Waals surface area are crucial for binding of ligands to the PPAR- receptor. Docking studies between receptor and most active compound supports the fact that hydrogen bonding interaction is important for binding interaction of ligands to the receptors, which is confirmed by the pharmacophore studies. Thus, the hydroxyl group is found to be significant for the binding of ligand to the receptor, as justified by the pharmacophore modelling and docking studies.
